Business Wire

CAMARCO-AD-HOC-GROUP

Share
Bondholder: Vietnam’s No Va Land at risk of acceleration notice if it fails to negotiate restructuring in good faith

To avoid issuance of an acceleration notice, No Va Land Investment Group Corp. must engage with an Ad Hoc Group of international bondholders, comprising investors with a combined AUM in excess of USD15bn, holding over 75% of USD 300m convertible bonds, to negotiate a restructuring agreement in good faith. An acceleration notice would have a spiralling effect on other stakeholders; if unsecured creditors accelerate the debt to step to the front of the line, more senior (secured) creditors will likely accelerate, derailing the entire restructuring process underway with onshore creditors, risking bankruptcy. Furthermore, equity could be zeroed out, ceding control of the company to creditors.

The Trustee to No Va Land’s USD 300m convertible bonds, Bank of NY Mellon, has already issued multiple Event of Default notices, most recently on 17 July 2023, related to the missed coupon payment due 16 July 2023. Despite a process to negotiate a consensual restructuring in the wake of a forbearance agreement having been attempted, the Board of No Va Land has refused to engage with the group in good faith.

The case has implications for other Vietnamese conglomerates with debt trading at stressed levels and refinancing concerns. This is the first restructuring in the context of the Vietnam 2035 vision and government attempts to capitalise on the growing China + 1 strategy. The stalling of No Va Land’s restructuring almost certainly creates issues for other companies which are critical to the Vietnamese economy. This would seem entirely unsatisfactory for the government’s plans to achieve its ambitious GDP growth in 2H 2023, which will be reliant on foreign investment after GDP growth significantly slowed, to 3.7% in 1H 2023, from 8% in 2022.

The Ad Hoc Group, whose members have been significant investors in Vietnam over many years, are highly concerned about the prioritisation of onshore creditors over international investors. A failure to reach an agreement is significantly impacting Vietnam’s standing in the international financial market and damaging investor confidence in the country.

A bondholder said: “As long term and significant investors in Vietnam, we urge the Board of No Va Land to engage with us to reach a consensual agreement, rather than refusing to countenance serious negotiations. This is for the good of the company, its stakeholders and Vietnam’s standing among international investors. No Va Land’s proposal further erodes our confidence in the process, forcing us to consider an acceleration notice which would negatively impact creditors and likely wipe out equity. By negotiating with onshore investors while blatantly sidelining international investors, No Va Land is projecting the message that global investors will not be supported but overlooked in a default, which is not conducive to encouraging the FDI Vietnam needs to capitalise on the growing China + 1 investment strategy.”

European business confidence in Vietnam dropped 4.5 points in Q2 2023, its lowest level in over a decade (excluding the Covid pandemic) and worse than during the Vietnam banking crisis of 2012, according to a report by the European Chamber of Commerce in Vietnam. The number of businesses who plan no increase in FDI in Vietnam rose c.4% QoQ to 40%. The top two obstacles cited to doing business are unclear rules and regulations and administrative issues and difficulties.

Continued Foreign Direct Investments into Vietnam are required to support the rapid capital expenditure to scale domestic infrastructure spending and this all needs to be underpinned by a functioning restructuring regime.

Notes to Editors:

About the Ad Hoc Group

The Ad Hoc Group is a group of funds managed by international institutional investors. The group manages a combined AUM in excess of USD 15bn. The Ad Hoc group of creditors holds over 75% of No Va Land’s US$300m convertible bonds, due 2026.

About No Va Land Investment Group Corp

No Va Land is a Vietnamese developer active in residential property and luxury resorts. Founded in 2007, it is listed on the Singapore stock exchange. The company has been hit by a liquidity crisis in the Vietnamese real estate sector. In May this year, No Va Land delayed payments on a VND 1 trillion ($42.6 m) bond that matured on 18 May. Then in June, two board members, brought in as part of the restructuring process, both formerly senior leaders at state-owned Gelex Group, stepped down less than a month after their appointment, Ms. Do Thi Phuong Lan and Mr. Nguyen Tran Dang Phuoc. Then on 16 July the company did not make the interest payment on notes due, to allow the company to maintain sufficient cash for ongoing operations.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230924901706/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

4Moving Biotech Enrolls First Patient in Phase 2a Trial of 4P004, a Potential First-in-Class GLP-1 Therapy for Knee Osteoarthritis16.7.2025 07:00:00 CEST | Press release

- First patient enrolled in INFLAM MOTION, a global randomized Phase 2a trial including 129 knee osteoarthritis patients - 4P004 to be evaluated over 3 months for dual efficacy: symptom relief and synovial health improvement via contrast-enhanced MRI - Topline results expected in the second half of 2026 4Moving Biotech (4MB), a spin-off of 4P-Pharma dedicated to developing first-in-class treatments that modify the natural course of knee osteoarthritis (OA), today announced that the first patient has been enrolled in Phase 2a clinical trial, INFLAM MOTION. The study will evaluate 4P004, an intra-articular GLP-1 analog, as a potential first-in-class therapeutic candidate for knee osteoarthritis. INFLAM MOTION is a multicenter, randomized, double-blind, placebo-controlled Phase 2a trial planned to be conducted across Europe, the United States, and Canada. A total of 129 patients worldwide diagnosed with knee OA will be enrolled to evaluate, for the first time in humans, the efficacy of 4P

Belkin Achieves Qi2.2 Certification for Its Upcoming Products, Unlocking the Future of 25W Wireless Charging15.7.2025 19:06:00 CEST | Press release

With Qi2.2 certification, Belkin reinforces its commitment to quality, safety, and performance for the next generation of wireless charging Belkin, a leading consumer electronics brand for over 40 years, today announced it has received official Qi2.2 certification from the Wireless Power Consortium (WPC) for its upcoming products. As one of the first accessory brands to deliver Qi2.2-certified devices, Belkin is helping bring the next generation of wireless charging to market – enabling faster wireless charging speeds, broader compatibility, and improved performance for consumers. Belkin’s close partnership with the WPC since 2015 has been instrumental in bringing these advancements to consumers. As an early adopter and long-time contributor to WPC standards, Belkin was selected as one of a small group of trusted manufacturers to test and certify Qi2.2 products ahead of the broader industry rollout. All Belkin products undergo rigorous safety, quality, and performance testing. The comp

Cessna Grand Caravan EX to Feature New Executive Interior Options, Expanding Opportunities for Elevated Missions15.7.2025 18:05:00 CEST | Press release

The legendary Cessna Grand Caravan EX will now feature three new executive interior schemes for customers to select when designing their aircraft cabin. The Lunar, Obsidian and Saddle Sport interiors join the existing Canyon and Savanna schemes, providing a broader range of standard choices. The new interior options are available to customers starting this month and allow them to further tailor the interior of their aircraft based on their personal preference or mission. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250715021096/en/ Cessna Grand Caravan EX to feature new executive interior options, expanding opportunities for elevated missions (Photo Credit: Textron Aviation) The Cessna Grand Caravan EX is designed and manufactured by Textron Aviation Inc., a Textron Inc. (NYSE:TXT) company. Premium versions of each of the new interiors are also available, featuring quilted seat stitching and plush carpet, providing an elev

7 Million Tokens Sells Out in less than One Hour—$MBG Token Pre-Sale Shatters Expectations15.7.2025 17:27:00 CEST | Press release

MultiBank Group, the world’s largest and most regulated financial derivatives institution, has set a new benchmark in digital asset launches. The Group’s $MBG Token Pre-Sale sold out in less than one hour with all 7 million tokens fully subscribed across MultiBank.io and Uniswap. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250715055611/en/ The Group’s $MBG Token Pre-Sale sold out in less than one hour with all 7 million tokens fully subscribed across MultiBank.io and Uniswap. Commenting on the success of the Pre-Sale, Naser Taher, Founder and Chairman of MultiBank Group, said: “The sell-out of our initial $MBG Token offering in less than one hour is a decisive validation of our vision. In a market saturated with speculation, the response we received confirms that institutional-grade transparency, regulatory integrity, and asset-backed value are what investors are now demanding. $MBG is here for the long term, reflecting t

First Patient Enrolled in National Cancer Institute’s Vanguard Study Evaluating Guardant Health’s Shield Multi-Cancer Detection Test15.7.2025 17:01:00 CEST | Press release

Study addressing feasibility of using multi-cancer detection tests in future trials aims to enroll up to 24,000 participantsShield MCD reviewed by FDA as part of NCI’s investigational device exemption (IDE) Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that patient enrollment has begun in the National Cancer Institute (NCI)’s Vanguard Study to evaluate emerging multi-cancer detection (MCD) technology. Guardant’s Shield™ MCD test was selected for use in the four-year study, which aims to enroll up to 24,000 patients and evaluate the use of MCD tests—blood tests that can screen for several types of cancer simultaneously—in future randomized controlled trials. Guardant’s Shield MCD test was chosen for the study based on the overall performance of its Shield platform in detecting 10 cancer types, including lung, breast, colorectal, prostate, bladder, ovarian, pancreatic, esophageal, liver and gastric. The data were presented at the 2025 American

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye